The two agencies have agreed to share research and knowledge
Category: Uncategorized
Clinigen has bagged a US orphan drug designation (ODD) for its investigational Amyotrophic Lateral Sclerosis (ALS) treatment aldesleukin.
GSK’s national TV push for Nucala gives another meaning to ‘new normal’ beth.bulik Sun, 07/12/2020 – 19:00
Updated Date: Mon, 06 Jul 2020 00:00:00 EDT
Updated Date: Mon, 06 Jul 2020 00:00:00 EDT
Updated Date: Mon, 06 Jul 2020 00:00:00 EDT
Updated Date: Mon, 06 Jul 2020 00:00:00 EDT
Updated Date: Mon, 06 Jul 2020 00:00:00 EDT
Lopinavir is a drug against HIV, hydroxychloroquine is used to treat malaria and rheumatism. Until recently, both drugs […]
FiercePharmaAsia—Boehringer’s Shanghai R&D hub; COVID-19 lessons from China; Botox trade secret war aliu Fri, 07/10/2020 – 05:52